CCG
CNTB

Catalina Capital Group’s Connect Biopharma Holdings CNTB Stock Holding History

Catalina Capital Group’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-47,867
Closed -$66.1K – 227
2024
Q4 		$66.1K Buy
+47,867
New +$55.1K 0.02% 339

Other funds holding CNTB

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Catalina Capital Group's CNTB Position: Q1 2025 in Review

Catalina Capital Group sold out of Connect Biopharma Holdings (CNTB) in Q1 2025, closing a stake of 47,867 shares — an estimated $66.1K sold.

Catalina Capital Group first reported a position in CNTB in Q4 2024 and held it in 1 quarter. The position peaked at $66.1K in Q4 2024. 13 funds tracked by Wall St. Rank hold CNTB as of Q1 2025.

  • Catalina Capital Group reported no remaining Connect Biopharma Holdings position as of Q1 2025 after selling out during the quarter.
  • Catalina Capital Group sold 47,867 Connect Biopharma Holdings shares in Q1 2025, an estimated $66.1K.
  • Catalina Capital Group first reported a position in Connect Biopharma Holdings in Q4 2024 and held it in 1 quarter.
  • Catalina Capital Group's Connect Biopharma Holdings position peaked at $66.1K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2025.

Based on Catalina Capital Group's 13F filing for Q1 2025, filed 21 Apr 2025.